In recent years, the landscape of muscle-invasive bladder cancer (MIBC) treatment has undergone a profound transformation, propelled by advances in...
Hepatocellular carcinoma (HCC) remains one of the deadliest cancer types globally, accounting for substantial cancer-related mortality despite ongoing advances in...
In a groundbreaking study published recently in the British Journal of Cancer, researchers from an international consortium have shed new...
A groundbreaking advancement in the treatment of muscle-invasive bladder cancer has emerged from recent clinical research at NYU Langone Health’s...
A groundbreaking study published in Nature Communications reveals a complex and mutually beneficial relationship between two bacterial species in the...
Groundbreaking study from Queen Mary University of London sheds new light on prostate cancer screening, revealing that the risk of...
A groundbreaking study led by researchers at UCLA has uncovered a compelling correlation between federal housing assistance and enhanced survival...
Cancer Drugs’ Unexpected Assault on Taste Buds Unveiled: New Study Illuminates Cellular Disruption Behind Dysgeusia In a groundbreaking study emerging...
In a groundbreaking advancement poised to transform cancer prognosis and treatment, researchers at Oregon Health & Science University (OHSU), funded...
Oregon Health & Science University (OHSU) researchers have unveiled a groundbreaking computational approach, termed scSurvival, which harnesses the power of...
In a groundbreaking development for the treatment of advanced oesophagogastric adenocarcinoma, the final analysis of the PLATFORM trial has been...
WASHINGTON — In a compelling new study that sheds light on adolescent behavior related to sun exposure, researchers funded by...
In a groundbreaking advancement poised to revolutionize early cancer detection, researchers have developed an enhanced multicancer screening assay leveraging whole-genome...
In a groundbreaking advancement in oral cancer prevention, researchers at The University of Texas MD Anderson Cancer Center have unveiled...
Glioblastoma, notoriously recognized as the most prevalent and aggressive form of brain tumor in adults, remains one of the most...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapeutics, offering remarkable benefits across multiple malignancies, including hepatocellular carcinoma (HCC). However, their...
In a compelling new study unveiled at the American Association for Cancer Research (AACR) Annual Meeting 2026, scientists have established...
In a groundbreaking phase I clinical trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, researchers...
In recent years, immune checkpoint inhibitors (ICIs) have revolutionized the landscape of cancer treatment, offering profound therapeutic benefits by harnessing...
In a groundbreaking endeavor to transform pediatric cancer research, the Damon Runyon Cancer Research Foundation and St. Jude Children’s Research...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.